Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
August 4, 2022
Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal Antibodies
Jeffrey R Simard, Klaus Michelsen, Yan Wang, et al.
Journal of Neuromuscular Diseases
|
November 19, 2016
Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory Adults
Samantha R Renusch, Sean Harshman, Hongyang Pi, et al.
Nature Structural & Molecular Biology
|
December 20, 2016
Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators
Xin Huang, Paul L Shaffer, Shawn Ayube, et al.
Frontiers in Cellular Neuroscience
|
April 18, 2022
Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and <i>p</i>CF3-diEPP
Katrin Richter, Roger L Papke, Clare Stokes, et al.
Plos One
|
May 15, 2009
Phase II open label study of valproic acid in spinal muscular atrophy
Kathryn J Swoboda, Charles B Scott, Sandra P Reyna, et al.
Plos One
|
September 3, 2010
SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy
Kathryn J Swoboda, Charles B Scott, Thomas O Crawford, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination
Ellen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Cancer Research
|
January 28, 2010
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation
Martin L Sos, Haridas B Rode, Stefanie Heynck, et al.
Plos One
|
July 15, 2011
SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy
John T Kissel, Charles B Scott, Sandra P Reyna, et al.
Muscle & Nerve
|
May 18, 2013
SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy
John T Kissel, Bakri Elsheikh, Wendy M King, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
The Journal of Pharmacology and Experimental Therapeutics
|
August 4, 2022
Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal Antibodies
Jeffrey R Simard, Klaus Michelsen, Yan Wang, et al.
Journal of Neuromuscular Diseases
|
November 19, 2016
Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory Adults
Samantha R Renusch, Sean Harshman, Hongyang Pi, et al.
Nature Structural & Molecular Biology
|
December 20, 2016
Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators
Xin Huang, Paul L Shaffer, Shawn Ayube, et al.
Frontiers in Cellular Neuroscience
|
April 18, 2022
Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and <i>p</i>CF3-diEPP
Katrin Richter, Roger L Papke, Clare Stokes, et al.
Plos One
|
May 15, 2009
Phase II open label study of valproic acid in spinal muscular atrophy
Kathryn J Swoboda, Charles B Scott, Sandra P Reyna, et al.
Plos One
|
September 3, 2010
SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy
Kathryn J Swoboda, Charles B Scott, Thomas O Crawford, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination
Ellen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Cancer Research
|
January 28, 2010
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation
Martin L Sos, Haridas B Rode, Stefanie Heynck, et al.
Plos One
|
July 15, 2011
SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy
John T Kissel, Charles B Scott, Sandra P Reyna, et al.
Muscle & Nerve
|
May 18, 2013
SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy
John T Kissel, Bakri Elsheikh, Wendy M King, et al.
Page
of 15